Johnson Matthey (JMAT)

Johnson Matthey Plc is a global specialty chemicals company operating in three divisions: Environmental Technologies, Precious Metal Products and Fine Chemicals. Environmental Technologies is a supplier of catalysts and related technologies for applications, such as pollution control, cleaner fuel, hydrocarbons and the hydrogen economy. Precious Metal Products’ activities comprise the marketing, distribution, refining and recycling of platinum group metals (pgms), fabrication of products using precious metals and related materials, manufactures pgm and base metal catalysts and pgm chemicals. Fine Chemicals is a supplier of active pharmaceutical ingredients, fine chemicals and other specialty chemical products and services to chemical and pharmaceutical industry’s customer supplier of catalysts. In March 2012, Endo Pharmaceuticals Holdings Inc. acquired U.S. patent 7,851,482 B2 for oxymorphone hydrochloride from the Company. In March 2013, the Company acquired Formox AB.

Directors: Niel Carson (CEO) 55, Robert MacLeod (Fin. Dir.) , Larry Pentz (Exec. Dir.) 57, W. Sandford (Exec. Dir.) 59, Simon Farrant (Secy.) ,

No. of Employees: 10,058 No. of Shareholders: 10,376

Last Annual	March 31st, 2012
Last Interim	September 30th, 2012
Shares in Issue	204,916,577
Free Float	198.0m (96.6%)

Sector	Industrials
Industry	Professional & Commercial Services
Index	FTSEUROFIRST 300 , E300 ex EURO COR, FTSE 350 Act , FTSE Lower Yield , FT350 Chemicals , FTSE 100 , FTSE 100 Eod Gbp ,
Exchange	London Stock Exchange (Full)
Eligible for	an ISA? a SIPP?